Lipocine Inc. SEC filings LPCN

Lipocine Inc. has 823 filings in SEC EDGAR's recent list, going back to Nov 30, 2011. Its latest annual report, Form 10-K, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Lipocine Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Other events
Oct 20, 2026 Oct 20, 2026
8-K Current report
Other events
Oct 7, 2026 Oct 7, 2026
4 Insider transaction Oct 1, 2026 Sep 29, 2026
4 Insider transaction Sep 30, 2026 Sep 28, 2026
8-K Current report
Other events
Sep 16, 2026 Sep 16, 2026
8-K Current report
Other events
Sep 14, 2026 Sep 14, 2026
8-K Current report
Other events
Sep 11, 2026 Sep 8, 2026
8-K Current report
Other events
Sep 10, 2026 Sep 10, 2026
8-K/A Amended current report
Officer or director change
Aug 21, 2026 Aug 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Aug 7, 2026 Aug 3, 2026
3 Initial insider ownership Aug 7, 2026 Aug 3, 2026
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 3, 2026 Aug 3, 2026
4 Insider transaction Jun 30, 2026 Jun 29, 2026
8-K Current report
Other events
Jun 12, 2026 Jun 12, 2026
S-8 Employee stock plan registration Jun 9, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
8-K Current report
Other events
Jun 4, 2026 Jun 4, 2026
8-K Current report
Other events
May 26, 2026 May 26, 2026
8-K Current report
Other events
May 19, 2026 May 19, 2026
8-K Current report
Other events
May 18, 2026 May 18, 2026
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
8-K Current report
Other events
May 7, 2026 May 7, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
DEFA14A Additional proxy material Apr 21, 2026 —
DEF 14A Proxy statement Apr 21, 2026 Apr 21, 2026
8-K Current report
Officer or director change
Apr 21, 2026 Apr 16, 2026
4 Insider transaction Apr 7, 2026 Apr 7, 2026
4 Insider transaction Apr 6, 2026 Apr 6, 2026
4 Insider transaction Apr 6, 2026 Apr 6, 2026
4 Insider transaction Apr 2, 2026 Apr 2, 2026
8-K Current report
Other events
Apr 2, 2026 Apr 2, 2026
8-K Current report
Other events
Apr 2, 2026 Apr 2, 2026
8-K Current report
Results of operations
Mar 10, 2026 Mar 10, 2026
10-K Annual report Mar 10, 2026 Dec 31, 2025
8-K Current report
Other events
Mar 4, 2026 Feb 26, 2026
424B5 Prospectus supplement Feb 26, 2026 —
8-K Current report
Other events
Feb 18, 2026 Feb 18, 2026
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Feb 18, 2026 Feb 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
8-K Current report
Other events
Jan 20, 2026 Jan 20, 2026
8-K Current report
Other events
Jan 12, 2026 Jan 12, 2026
8-K Current report
Other events
Jan 12, 2026 Jan 12, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
SCHEDULE 13G Ownership over 5% (passive) Dec 23, 2025 —
4 Insider transaction Dec 19, 2025 Dec 18, 2025
4 Insider transaction Dec 19, 2025 Dec 18, 2025
8-K Current report
Other events
Dec 16, 2025 Dec 15, 2025
8-K Current report
Officer or director change
Dec 15, 2025 Dec 12, 2025
8-K Current report
Other events
Dec 11, 2025 Dec 8, 2025
8-K Current report
Other events
Nov 18, 2025 Nov 18, 2025
8-K Current report
Other events
Nov 18, 2025 Nov 18, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Other events
Nov 4, 2025 Nov 4, 2025
8-K Current report
Other events
Sep 30, 2025 Sep 30, 2025
8-K Current report
Other events
Sep 26, 2025 Sep 26, 2025
8-K Current report
Other events
Sep 5, 2025 Sep 5, 2025
8-K Current report
Other events
Sep 5, 2025 Sep 5, 2025
8-K Current report
Other events
Aug 26, 2025 Aug 26, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Other events
Jul 9, 2025 Jul 9, 2025
8-K Current report
Other events
Jul 2, 2025 Jul 2, 2025
8-K Current report
Other events
Jun 26, 2025 Jun 26, 2025
8-K Current report
Other events
Jun 23, 2025 Jun 23, 2025
8-K Current report
Other events
Jun 9, 2025 Jun 9, 2025
4 Insider transaction Jun 5, 2025 Jun 4, 2025
4 Insider transaction Jun 5, 2025 Jun 4, 2025
4 Insider transaction Jun 5, 2025 Jun 4, 2025
4 Insider transaction Jun 5, 2025 Jun 4, 2025
4 Insider transaction Jun 5, 2025 Jun 4, 2025
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 4, 2025 Jun 4, 2025
8-K Current report
Other events
May 22, 2025 May 22, 2025
8-K Current report
Other events
May 14, 2025 May 14, 2025
8-K Current report
Other events
May 12, 2025 May 12, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Other events
May 8, 2025 May 8, 2025
8-K Current report
Other events
May 6, 2025 May 6, 2025
DEF 14A Proxy statement Apr 22, 2025 Dec 31, 2024
PRE 14A Preliminary proxy statement Apr 10, 2025 Dec 31, 2024
8-K Current report
Other events
Apr 3, 2025 Apr 3, 2025
8-K Current report
Other events
Mar 26, 2025 Mar 26, 2025
8-K Current report
Other events
Mar 13, 2025 Mar 13, 2025
10-K Annual report Mar 13, 2025 Dec 31, 2024
8-K Current report
Other events
Mar 12, 2025 Mar 12, 2025
8-K Current report
Other events
Feb 11, 2025 Feb 11, 2025
8-K Current report
Other events
Feb 6, 2025 Feb 6, 2025
8-K Current report
Other events
Jan 13, 2025 Jan 13, 2025
4/A Filing Jan 2, 2025 Jan 2, 2025
4 Insider transaction Jan 2, 2025 Jan 2, 2025
4 Insider transaction Dec 30, 2024 Dec 23, 2024
4 Insider transaction Dec 30, 2024 Dec 23, 2024
8-K Current report
Other events
Dec 17, 2024 Dec 17, 2024
8-K Current report
Other events
Dec 13, 2024 Dec 13, 2024
8-K Current report
Other events
Nov 18, 2024 Nov 18, 2024
8-K Current report
Other events
Nov 7, 2024 Nov 7, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Other events
Nov 5, 2024 Nov 5, 2024
8-K Current report
Other events
Oct 31, 2024 Oct 28, 2024
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change
Oct 23, 2024 Oct 22, 2024
8-K Current report
Other events
Oct 16, 2024 Oct 16, 2024
8-K Current report
Other events
Oct 10, 2024 Oct 10, 2024
8-K Current report
Other events
Oct 8, 2024 Oct 8, 2024
8-K Current report
Other events
Oct 8, 2024 Oct 7, 2024
8-K Current report
Other events
Oct 2, 2024 Oct 2, 2024
8-K Current report
Other events
Sep 30, 2024 Sep 30, 2024
8-K Current report
Other events
Sep 5, 2024 Sep 5, 2024
8-K Current report
Other events
Aug 27, 2024 Aug 27, 2024
8-K Current report
Other events
Aug 8, 2024 Aug 8, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K/A Amended current report
Shareholder vote results
Aug 7, 2024 Jun 5, 2024
8-K Current report
Other events
Jun 25, 2024 Jun 25, 2024
8-K Current report
Other events
Jun 10, 2024 Jun 8, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
8-K Current report
Shareholder vote results
Jun 5, 2024 Jun 5, 2024
8-K Current report
Officer or director change, Other events
Jun 3, 2024 May 18, 2024
DEFA14A Additional proxy material Jun 3, 2024 —
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Other events
May 9, 2024 May 9, 2024
8-K Current report
Other events
May 8, 2024 May 8, 2024
8-K Current report
Other events
May 1, 2024 May 1, 2024
8-K Current report
Other events
Apr 29, 2024 Apr 29, 2024
8-K Current report
Material agreement, Agreement ended
Apr 26, 2024 Apr 26, 2024
424B5 Prospectus supplement Apr 26, 2024 —
EFFECT Filing Apr 25, 2024 —
CORRESP Letter to the SEC Apr 24, 2024 —
S-3/A Filing Apr 23, 2024 —
DEF 14A Proxy statement Apr 23, 2024 Apr 23, 2024
8-K Current report
Other events
Apr 11, 2024 Apr 11, 2024
8-K Current report
Other events
Mar 28, 2024 Mar 28, 2024
8-K Current report
Other events
Mar 25, 2024 Mar 25, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
8-K Current report
Other events
Mar 7, 2024 Mar 7, 2024
8-K Current report
Results of operations
Mar 7, 2024 Mar 7, 2024
10-K Annual report Mar 7, 2024 Dec 31, 2023
8-K Current report
Other events
Mar 6, 2024 Mar 6, 2024
8-K Current report
Other events
Feb 12, 2024 Feb 12, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Jan 18, 2024 Jan 18, 2024
8-K Current report
Other events
Jan 9, 2024 Jan 8, 2024
8-K Current report
Other events
Dec 19, 2023 Dec 19, 2023
UPLOAD Letter from the SEC Nov 29, 2023 —
S-3 Shelf registration Nov 22, 2023 —
8-K Current report
Other events
Nov 13, 2023 Nov 13, 2023
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Other events
Nov 8, 2023 Nov 8, 2023
8-K Current report
Other events
Nov 1, 2023 Nov 1, 2023
8-K Current report
Other events
Oct 26, 2023 Oct 26, 2023
8-K Current report
Other events
Oct 24, 2023 Oct 23, 2023
8-K Current report
Agreement ended
Oct 6, 2023 Oct 2, 2023
8-K Current report
Other events
Sep 19, 2023 Sep 19, 2023
8-K Current report
Other events
Aug 10, 2023 Aug 10, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Other events
Jul 27, 2023 Jul 27, 2023
8-K Current report
Other events
Jun 26, 2023 Jun 26, 2023
8-K Current report
Other events
Jun 26, 2023 Jun 26, 2023
8-K Current report
Other events
Jun 23, 2023 Jun 23, 2023
8-K Current report
Other events
Jun 14, 2023 Jun 14, 2023
8-K Current report
Other events
Jun 7, 2023 Jun 7, 2023
8-K Current report
Other events
May 31, 2023 May 31, 2023
4 Insider transaction May 25, 2023 May 25, 2023
8-K Current report
Other events
May 16, 2023 May 16, 2023
4 Insider transaction May 12, 2023 May 10, 2023
4 Insider transaction May 12, 2023 May 10, 2023
4 Insider transaction May 12, 2023 May 10, 2023
4 Insider transaction May 12, 2023 May 10, 2023
4 Insider transaction May 12, 2023 May 10, 2023
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
May 11, 2023 May 10, 2023
8-K Current report
Other events
May 11, 2023 May 11, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Other events
May 5, 2023 May 5, 2023
424B5 Prospectus supplement Apr 3, 2023 —
8-K Current report
Officer or director change, Other events
Apr 3, 2023 Mar 7, 2023
DEF 14A Proxy statement Mar 27, 2023 Mar 27, 2023
4 Insider transaction Mar 24, 2023 Mar 24, 2023
4 Insider transaction Mar 20, 2023 Mar 20, 2023
ARS Annual report to shareholders Mar 20, 2023 Dec 31, 2022
4 Insider transaction Mar 17, 2023 Mar 17, 2023
PRE 14A Preliminary proxy statement Mar 17, 2023 Mar 17, 2023
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 13, 2023
10-K Annual report Mar 10, 2023 Dec 31, 2022
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Mar 10, 2023 Mar 7, 2023
8-K Current report
Other events
Mar 10, 2023 Mar 10, 2023
8-A12G Filing Mar 10, 2023 —
8-K Current report
Other events
Jan 11, 2023 Jan 11, 2023
8-K Current report
Other events
Jan 5, 2023 Jan 5, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LPCN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Salt Lake City, United States
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1535955
Former names
MARATHON BAR CORP (until Jul 9, 2013)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.